[CLDX] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
12-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 3.11%
YoY- -57.57%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 407 153 668 546 941 3,924 2,220 -24.61%
PBT -26,784 -20,679 -14,224 -11,413 -7,243 -31,563 -29,598 -1.65%
Tax -912 -227 1,088 -5,090 -14,912 -5,200 -790 2.42%
NP -26,784 -20,452 -14,224 -11,413 -7,243 -26,363 -29,598 -1.65%
Tax Rate - - - - - - - -
Total Cost 27,191 20,605 14,892 11,959 8,184 30,287 31,818 -2.58%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -6,580.84 -13,367.32 -2,129.34 -2,090.29 -769.71 -671.84 -1,333.24 30.46%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.57 -0.45 -0.36 -0.75 -0.66 -3.05 -4.41 -28.88%
EPS Diluted -0.57 -0.45 -0.36 -0.75 -0.66 -3.05 -4.41 -28.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.